Afasevikumab (RG 7624) is a fully humanised monoclonal antibody that targets and neutralises IL-17A and IL-17F, and can be used to study autoimmune diseases and inflammation.
Purity:
95.30%
CAS Number:
[1589503-30-9]
Target:
IL Receptor|||Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted